Autism Spectrum Disorders Clinical Trial
Official title:
Emotion Regulation in Preschoolers With Autism and Their Parents
Verified date | September 2013 |
Source | Meir Medical Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | Israel: Ethics Commission |
Study type | Observational |
In the proposed study, the investigators would like to investigate the emotion regulation
(ER) strategies children with Autism Spectrum Disorders (ASD) demonstrate, and the influence
parents have on their children's ER. More specifically, the investigators would like to
examine what are the ER mechanisms that parents use, what mechanisms of self regulation
children with autism internalize, and how parents support and improve the ER capabilities of
their child with ASD. These will be studied in a behavioral level, using micro-analysis of
parent-child interaction, and in a physiological level, using indexes of stress control and
affiliation. In addition, in order for parental ER support to be effective, it is important
to consider more innate neuro-developmental difficulties children with ASD demonstrate that
strongly affect their ability to regulate themselves. These include sensory regulation
difficulties, temperament, attention disorders and poor executive functioning.
Hypotheses:
1. ER strategies used by children with ASD will be more poorly developed and less
effective, compared to those of children in the control groups.
2. Difficult temperament and sensory regulation difficulties will hamper ER in children
with ASD.
3. ER strategies of parents of children with ASD will be more poorly developed and less
effective than those of parents in the control groups.
4. Good parental self-ER and parental attunement to the child will be predictive of
improved ER in children with ASD, and in parent-child synchrony, both in the behavioral
and in the physiological levels.
Status | Completed |
Enrollment | 80 |
Est. completion date | May 2011 |
Est. primary completion date | May 2011 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 3 Years to 6 Years |
Eligibility |
Inclusion Criteria: - For the study group:Children diagnosed with ASD - For the comparison group:Children with typical development Exclusion Criteria: - For the study group:Non verbal children. - For the comparison group: Any major developmental disability. |
Observational Model: Case Control, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
Israel | Brill Mental Health Center | Tel Aviv |
Lead Sponsor | Collaborator |
---|---|
Meir Medical Center |
Israel,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Emotion regulation(ER)strategies during emotion eliciting episodes | The Frequency,duration and percentage of ER behaviors presented by the child and the parent will be coded microanalytically using computerized coding system: The Observer, Noldus Co., Waggeniggen, The Netherlands | During a 2hr home visit, while the child interacts with the parent | No |
Secondary | Salivary hormone levels: Cortisol and Oxytocin of both parent and child | Changes in salivary Cortisol amd Oxytpcin levels over 3 time points during the home visit, before and after emotionally arousing activities. Collected from both parent and child. | collected 4 times during the assessment meeting, from both child and parent. | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT02625116 -
ELENA Cohort: A Long-term Longitudinal Study in a Pediatric Sample With Autism Spectrum Disorders
|
||
Not yet recruiting |
NCT06381856 -
Improving Participation of Autistic Children and Adolescents in the Habilitation Process
|
||
Recruiting |
NCT02280746 -
Gluten for Autism Spectrum Disorders
|
N/A | |
Completed |
NCT01945957 -
Brain Imaging of Intranasal Oxytocin Treatment in Autism
|
Phase 1 | |
Completed |
NCT01661855 -
A Pilot Study of Riluzole Versus Placebo in the Treatment of Children and Adolescents With ASD
|
Phase 2 | |
Completed |
NCT01691066 -
Pivotal Response Treatment for Infants At-Risk for Autism Spectrum Disorder
|
N/A | |
Completed |
NCT01780090 -
Handheld Technology for Speech Development in Students With Autism
|
N/A | |
Completed |
NCT01694667 -
Omega-3 Fatty Acids for Hyperactivity Treatment in Autism Spectrum Disorder
|
Phase 2 | |
Completed |
NCT01592747 -
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
|
Phase 2 | |
Active, not recruiting |
NCT01417026 -
Intranasal Oxytocin and Learning in Autism
|
Phase 2 | |
Enrolling by invitation |
NCT01364818 -
Brain Connectivity in Neurodevelopmental Disorders in Response to Treatment
|
N/A | |
Completed |
NCT01695200 -
Omega-3 Fatty Acids in Autism Spectrum Disorders
|
Phase 4 | |
Completed |
NCT02300597 -
Internet-based Support for Young People With ADHD and Autism - a Controlled Study
|
N/A | |
Completed |
NCT01675414 -
Understanding Gastrointestinal Conditions in Children With Autism Spectrum Disorder (ASD)
|
N/A | |
Not yet recruiting |
NCT00695812 -
The Development of Younger Siblings of Children With Autism Now at 10 Years of Age
|
N/A | |
Recruiting |
NCT05910502 -
Project AFECT (Autism Family Empowerment Coaching and Training Program)
|
N/A | |
Completed |
NCT02081027 -
Pilot Study of Riluzole for Drug-Refractory Irritability in Autism Spectrum Disorders
|
Early Phase 1 | |
Completed |
NCT02797379 -
The Development of a Psychoeducational Tool to Manage Anxiety in People With Autism Spectrum Disorders
|
N/A | |
Terminated |
NCT01730079 -
Near Infrared Spectroscopy in Children With Autism and ADHD
|
||
Completed |
NCT01603225 -
Transcranial Direct Current Stimulation and Autism
|